mesalamine has been researched along with Cancer of Gastrointestinal Tract in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazuro, GE | 1 |
| Torino, F | 1 |
| Gasparini, G | 1 |
| Capurso, L | 1 |
| Fehér, J | 1 |
| Prónai, L | 1 |
1 review available for mesalamine and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all?
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; ErbB Recepto | 2008 |
1 other study available for mesalamine and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
[The role of free radical scavengers in gastrointestinal diseases].
Topics: Aminosalicylic Acids; Antioxidants; Ascorbic Acid; Free Radical Scavengers; Gastrointestinal Disease | 1993 |